Please login to the form below

Not currently logged in
Email:
Password:

Axovant

This page shows the latest Axovant news and features for those working in and with pharma, biotech and healthcare.

Axovant drops last ‘legacy’ drug to focus on gene therapies

Axovant drops last ‘legacy’ drug to focus on gene therapies

Decision comes after nelotanserin failed to meet efficacy target. Shares in Axovant lost more than a quarter of their value yesterday after the Swiss biotech revealed that a trial of a ... The decision to scrap nelotanserin comes after Axovant’s

Latest news

More from news
Approximately 6 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics